Abstract

http://ssrn.com/abstract=2228068
 
 

References (157)



 
 

Footnotes (1)



 


 



Pharmaceutical Knowledge Governance: A Human Rights Perspective


Trudo Lemmens


University of Toronto - Faculty of Law

March 4, 2013

Journal of Law, Medicine and Ethics, Vol. 41(1), pp. 163-184, 2013

Abstract:     
Available at SSRN: http://ssrn.com/abstract=2228068

Industry control over the production, distribution and use of pharmaceutical safety and efficacy data is a serious global public health and health care funding concern. Various recent controversies, several of them involving the hiding of data and the misrepresentation of scientific data in some of the most influential medical journals, highlight the urgency of enhancing pharmaceutical knowledge governance. This paper analyzes this issue from a human rights perspective. The paper first identifies the global challenges associated with the current knowledge deficit. It then discusses, based on an analysis of case law, how various human rights associated interests can be invoked to support the claim that states have an obligation to actively contribute to reliable knowledge production systems, for example through ensuring transparency of data. The paper further discusses a conceptual use of human rights, as a methodology which requires a comprehensive analysis of the different interwoven historical, economic, cultural and social factors that contribute to the problem. Such an analysis reveals that historically grown drug regulations, aimed at the protection of the public, in combination with other socio-cultural and economic factors, have in fact increased industry control over pharmaceutical knowledge production. This finding should inform needed reforms of drug regulation. The paper ends with a recommendation for a comprehensive global response to the problems with pharmaceutical knowledge governance.

Number of Pages in PDF File: 22

Keywords: pharmaceutical regulation, pharmaceutical law, human rights, knowledge governance, right to health, right to information, access to data, transparency, evidence based medicine, clinical trials, data exclusivity, intellectual property, international trade law, TRIPS, fraud

JEL Classification: F13, H23, H41, I18, I10, K23, K13, L15, L65

Accepted Paper Series


Download This Paper

Date posted: March 5, 2013 ; Last revised: April 6, 2014

Suggested Citation

Lemmens, Trudo, Pharmaceutical Knowledge Governance: A Human Rights Perspective (March 4, 2013). Journal of Law, Medicine and Ethics, Vol. 41(1), pp. 163-184, 2013. Available at SSRN: http://ssrn.com/abstract=2228068

Contact Information

Trudo Lemmens (Contact Author)
University of Toronto - Faculty of Law ( email )
78 and 84 Queen's Park
Toronto, Ontario M5S 2C5
Canada
Feedback to SSRN


Paper statistics
Abstract Views: 1,378
Downloads: 161
Download Rank: 103,509
References:  157
Footnotes:  1

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo2 in 5.047 seconds